Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
Clinical trial NCT06633718 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06633718
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2027-05-30
- Enrollment
- 786
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.